Cita APA

Castellano Esparza, E. (2025). Development of CRISPR/Cas9 multi-edited cord blood-derived CAR NK cells to improve their persistence and antitumor potential against Multiple Myeloma.

Citación estilo Chicago

Castellano Esparza, Eva. Development of CRISPR/Cas9 Multi-edited Cord Blood-derived CAR NK Cells to Improve Their Persistence and Antitumor Potential against Multiple Myeloma. 2025.

Cita MLA

Castellano Esparza, Eva. Development of CRISPR/Cas9 Multi-edited Cord Blood-derived CAR NK Cells to Improve Their Persistence and Antitumor Potential against Multiple Myeloma. 2025.